JP2001521482A5 - - Google Patents

Download PDF

Info

Publication number
JP2001521482A5
JP2001521482A5 JP1997503457A JP50345797A JP2001521482A5 JP 2001521482 A5 JP2001521482 A5 JP 2001521482A5 JP 1997503457 A JP1997503457 A JP 1997503457A JP 50345797 A JP50345797 A JP 50345797A JP 2001521482 A5 JP2001521482 A5 JP 2001521482A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997503457A
Other languages
English (en)
Japanese (ja)
Other versions
JP4016133B2 (ja
JP2001521482A (ja
Filing date
Publication date
Priority claimed from AUPN3667A external-priority patent/AUPN366795A0/en
Application filed filed Critical
Publication of JP2001521482A publication Critical patent/JP2001521482A/ja
Publication of JP2001521482A5 publication Critical patent/JP2001521482A5/ja
Application granted granted Critical
Publication of JP4016133B2 publication Critical patent/JP4016133B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP50345797A 1995-06-20 1996-06-20 ペプチド放出のための新規な製剤 Expired - Lifetime JP4016133B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU3667 1989-04-12
AUPN3667A AUPN366795A0 (en) 1995-06-20 1995-06-20 Formulation for preventing reproductive function
PCT/AU1996/000370 WO1997000693A1 (en) 1995-06-20 1996-06-20 Novel formulation for peptide release

Publications (3)

Publication Number Publication Date
JP2001521482A JP2001521482A (ja) 2001-11-06
JP2001521482A5 true JP2001521482A5 (enExample) 2004-08-05
JP4016133B2 JP4016133B2 (ja) 2007-12-05

Family

ID=3788008

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50345797A Expired - Lifetime JP4016133B2 (ja) 1995-06-20 1996-06-20 ペプチド放出のための新規な製剤

Country Status (16)

Country Link
US (2) US5925619A (enExample)
EP (1) EP0871467B1 (enExample)
JP (1) JP4016133B2 (enExample)
CN (1) CN1145496C (enExample)
AT (1) ATE223726T1 (enExample)
AU (2) AUPN366795A0 (enExample)
CA (1) CA2225796C (enExample)
DE (2) DE69623652T2 (enExample)
DK (1) DK0871467T3 (enExample)
ES (1) ES2182983T3 (enExample)
FR (1) FR08C0001I2 (enExample)
NL (1) NL300330I2 (enExample)
NZ (1) NZ309697A (enExample)
PT (1) PT871467E (enExample)
SI (1) SI0871467T1 (enExample)
WO (1) WO1997000693A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN366795A0 (en) * 1995-06-20 1995-07-13 Peptide Technology Limited Formulation for preventing reproductive function
CA2264562C (en) 1996-08-30 2012-01-03 Peptech Limited Sustained peptide-release formulation
WO2000004897A1 (en) * 1998-07-20 2000-02-03 Peptech Limited Bioimplant formulation
US8052982B2 (en) * 1998-07-20 2011-11-08 Peptech Animal Health Pty Limited Bioimplant formulation comprising lecithin and stearin
US6211221B1 (en) * 1999-04-05 2001-04-03 Johnny W. Peterson Dietary supplement containing histidine for alleviating dysmenorrhea, endometriosis, and pre-term labor
AU2001295359A1 (en) * 2000-10-30 2002-05-15 University Of Zurich GnRH analogues for treatment of urinary incontinence
GB0221539D0 (en) * 2002-09-17 2002-10-23 Medical Res Council Methods of treatment
CA2552241C (en) * 2003-12-30 2013-10-01 Durect Corporation Co-polymeric devices for controlled release of active agents
US20080254086A1 (en) * 2004-12-23 2008-10-16 Brown James E Controlled Release Compositions
KR20100059863A (ko) * 2007-09-11 2010-06-04 몬도바이오테크 래보래토리즈 아게 치료제로서의 펩티드 티모신 베타 ４ 단독 또는 세크로핀 ａ와의 배합물의 용도
DE102008015104A1 (de) 2008-03-19 2009-09-24 Basf Coatings Ag Beschichtungszusammensetzung, Verfahren zu ihrer Herstellung, ihre Verwendung und mit ihr beschichtete Substrate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS563846B2 (enExample) * 1972-10-12 1981-01-27
US4218439A (en) * 1977-07-14 1980-08-19 The Salk Institute For Biological Studies Peptide which inhibits gonadal function
US4256737A (en) * 1979-06-11 1981-03-17 Syntex (U.S.A.) Inc. Long acting depot injectable formulations for LH-RH analogues
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
ATE74009T1 (de) * 1986-08-11 1992-04-15 American Cyanamid Co Zusammensetzungen zur parenteralen verabreichung und deren verwendung.
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
US5470582A (en) * 1992-02-07 1995-11-28 Syntex (U.S.A.) Inc. Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
AUPN366795A0 (en) * 1995-06-20 1995-07-13 Peptide Technology Limited Formulation for preventing reproductive function

Similar Documents

Publication Publication Date Title
JP2000500445A5 (enExample)
JP2000500440A5 (enExample)
JP2000500228A5 (enExample)
JPH11501247A5 (enExample)
JP2000500327A5 (enExample)
JPH11513500A5 (enExample)
JP2000500145A5 (enExample)
JP2000502919A5 (enExample)
JP2000500155A5 (enExample)
JP2000500406A5 (enExample)
JP2000500361A5 (enExample)
JP2000500115A5 (enExample)
JP2000500342A5 (enExample)
JP2000500192A5 (enExample)
JP2000500112A5 (enExample)
JP2000500226A5 (enExample)
JP2000500051A5 (enExample)
JP2000500166A5 (enExample)
JP2000500397A5 (enExample)
JP2000500407A5 (enExample)
JPH11509255A5 (enExample)
JP2000500125A5 (enExample)
JP2000500044A5 (enExample)
JP2000500257A5 (enExample)
JP2000500090A5 (enExample)